Stock listing
TARS Stock Price, News, Filings & Events — Tarsus Pharmaceuticals, Inc.
Selected listing: TARS · NASDAQ · USD · US
This page tracks Tarsus Pharmaceuticals, Inc.'s TARS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following TARS:NASDAQ. TARS:NASDAQ is the stock-level entry point for investors researching Tarsus Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Tarsus Pharmaceuticals, Inc. is a publicly traded company on the American stock market under the ticker TARS. The company has a market capitalization of approximately $2.57 billion. Tarsus focuses on developing innovative therapies to address unmet medical needs.
- Ticker
- TARS:NASDAQ
- Asset type
- Stock
- Market cap
- $3.48B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Tarsus Pharmaceuticals, Inc. TARS:NASDAQ stock context
This page tracks Tarsus Pharmaceuticals, Inc.'s TARS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following TARS:NASDAQ. TARS:NASDAQ is the stock-level entry point for investors researching Tarsus Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Tarsus Pharmaceuticals, Inc. is a publicly traded company on the American stock market under the ticker TARS. The company has a market capitalization of approximately $2.57 billion. Tarsus focuses on developing innovative therapies to address unmet medical needs.
Latest news from Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care
September 4, 2026
Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth
August 6, 2026
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position
August 6, 2026
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
August 6, 2026
Tarsus to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
August 5, 2026
Tarsus Pharmaceuticals, Inc. earnings calls
Tarsus Pharmaceuticals, Inc. (TARS) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Tarsus Pharmaceuticals, Inc. (TARS) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
Tarsus Pharmaceuticals, Inc. (TARS) Q4 2025 Earnings Call
February 23, 2026 · Replay with transcript and chapters
Tarsus Pharmaceuticals, Inc. (TARS) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Tarsus Pharmaceuticals, Inc. (TARS) Q2 2025 Earnings Call
August 6, 2025 · Replay with transcript and chapters
Tarsus Pharmaceuticals, Inc. (TARS) Q1 2025 Earnings Call
May 1, 2025 · Replay with transcript and chapters
Research Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for TARS:NASDAQ.
Tarsus Pharmaceuticals, Inc. company profile
View the public company page for Tarsus Pharmaceuticals, Inc. on 6ix.
Tarsus Pharmaceuticals, Inc. news
Read company news and market updates connected to Tarsus Pharmaceuticals, Inc..
Tarsus Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Tarsus Pharmaceuticals, Inc..